Cancer Stem Cell and Hepatic Stellate Cells in Hepatocellular Carcinoma

Technol Cancer Res Treat. 2023 Jan-Dec:22:15330338231163677. doi: 10.1177/15330338231163677.

Abstract

Hepatocellular carcinoma (HCC) is the most common liver cancer. It is highly lethal and has high recurrence. Death among HCC patients occur mainly due to tumor progression, recurrence, metastasis, and chemoresistance. Cancer stem cells (CSCs) are cell subpopulations within the tumor that promote invasion, recurrence, metastasis, and drug resistance. Hepatic stellate cells (HSCs) are important components of the tumor microenvironment (TME) responsible for primary secretory ECM proteins during liver injury and inflammation. These cells promote fibrogenesis, infiltrate the tumor stroma, and contribute to HCC development. Interactions between HSC and CSC and their microenvironment help promote carcinogenesis through different mechanisms. This review summarizes the roles of CSCs and HSCs in establishing the TME in primary liver tumors and describes their involvement in HCC chemoresistance.

Keywords: cancer stem cells; chemoresistance; hepatic stellate cells; hepatocellular carcinoma.

Publication types

  • Review

MeSH terms

  • Carcinoma, Hepatocellular* / pathology
  • Cell Line, Tumor
  • Cell Movement
  • Hepatic Stellate Cells / metabolism
  • Hepatic Stellate Cells / pathology
  • Humans
  • Liver Neoplasms* / pathology
  • Neoplastic Stem Cells / metabolism
  • Tumor Microenvironment